Skip to content
Home/Companies/Biotech/Crescendo Biologics
CB

Crescendo Biologics

Biotech·UK·Active·8yr hold

Crescendo Biologics is a healthcare company, headquartered in United Kingdom.

Entry
2018
Hold
8yr
Status
Active
Est. EV
–

Who owns Crescendo Biologics?

Crescendo Biologics is currently owned by Sofinnova Partners through Sofinnova Capital IX (2018 vintage), since 2018. Across its history, Crescendo Biologics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital IX · 2018 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Andera Partners and Sofinnova Partners since 2018.
Co-invest · 2 holders · 2018 · present
Andera Partners
Andera PartnersActive
2018 · present · BioDiscovery 5 · 2017 · VC
MOIC
–
Sofinnova Partners
Sofinnova PartnersActive
2018 · present · Sofinnova Capital IX · 2018 · Life Sciences VC
MOIC
–

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

Asceneuron
Active
BiotechSwitzerland· 2020
CorVent Medical
Active
MedTechUS· 2020
Genespire
Active
BiotechItaly· 2020
Nitrase Therapeutics
Active
BiotechUS· 2020
Noema Pharma
Exited 2022
BiotechSwitzerland· 2020
to
Pi-Cardia
Active
MedTechIsrael· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings